OptimizeRx News

OptimizeRx Analyst Ratings

BenzingaMay 15 07:51 ET

Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)

TipRanksMay 15 06:56 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), PepGen Inc. (PEPG) and RegenXBio (RGNX)

TipRanksMay 15 06:31 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)

TipRanksMay 15 05:31 ET

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)

TipRanksMay 15 00:30 ET

Lake Street Sticks to Their Buy Rating for OptimizeRx (OPRX)

TipRanksMay 13 08:55 ET

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), OptimizeRx (OPRX) and AbbVie (ABBV)

TipRanksApr 29 05:50 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Alvotech (ALVO) and Pacific Biosciences (PACB)

TipRanksApr 17 03:30 ET

OptimizeRx Analyst Ratings

BenzingaApr 16 11:15 ET

Analysts Are Bullish on These Healthcare Stocks: OptimizeRx (OPRX), Day One Biopharmaceuticals (DAWN)

TipRanksApr 16 09:00 ET

Analysts Are Bullish on Top Healthcare Stocks: OptimizeRx (OPRX), Ocular Therapeutix (OCUL)

TipRanksApr 16 00:30 ET

OptimizeRx Analyst Ratings

BenzingaApr 4 05:00 ET

OptimizeRx Analyst Ratings

BenzingaApr 1 09:49 ET

Stifel Nicolaus Sticks to Their Buy Rating for OptimizeRx (OPRX)

TipRanksApr 1 08:35 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Walgreens Boots Alliance (WBA) and Kodiak Sciences (KOD)

TipRanksApr 1 03:40 ET

RBC Capital Keeps Their Buy Rating on OptimizeRx (OPRX)

TipRanksMar 29 21:45 ET

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)

TipRanksMar 12 09:02 ET

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and OptimizeRx (OPRX)

TipRanksJan 25 08:50 ET

RBC Adjusts OptimizeRx's Price Target to $17 From $14, Keeps Outperform Rating

MT NewswiresJan 10 10:24 ET

OptimizeRx Analyst Ratings

BenzingaJan 10 10:02 ET